These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3362066

  • 1. Fluorine-19 NMR imaging of glucose metabolism.
    Nakada T, Kwee IL, Card PJ, Matwiyoff NA, Griffey BV, Griffey RH.
    Magn Reson Med; 1988 Mar; 6(3):307-13. PubMed ID: 3362066
    [Abstract] [Full Text] [Related]

  • 2. F-19 MR imaging of glucose metabolism in the rabbit.
    Nakada T, Kwee IL, Griffey BV, Griffey RH.
    Radiology; 1988 Sep; 168(3):823-5. PubMed ID: 3136509
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Noninvasive evaluation of effects of an aldose reductase inhibitor in rat brain by 19F FDG NMR spectroscopy.
    Nakada T, Kwee IL.
    Magn Reson Med; 1987 Apr; 4(4):366-71. PubMed ID: 3108615
    [Abstract] [Full Text] [Related]

  • 8. Aldose reductase and sorbitol dehydrogenase activities in diabetic brain: in vivo kinetic studies using 19F 3-FDG NMR in rats.
    Kwee IL, Igarashi H, Nakada T.
    Neuroreport; 1996 Feb 29; 7(3):726-8. PubMed ID: 8733731
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of energy metabolism in brain using epimerization of 2-deoxy-2-fluoro-D-glucose by 19F NMR: the effect of anesthesia.
    Shinohara S, Kanazawa Y, Kojima M.
    Magn Reson Med; 1991 Oct 29; 21(2):191-6. PubMed ID: 1745118
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cerebral metabolism of fluorodeoxyglucose measured with 19F NMR spectroscopy.
    Pouremad R, Wyrwicz AM.
    NMR Biomed; 1991 Aug 29; 4(4):161-6. PubMed ID: 1931555
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 31P and 3-fluoro-3-deoxy-D-glucose 19F in vivo NMR spectroscopy of aged rat brain.
    Kwee IL, Nakada T, Suzuki N.
    NMR Biomed; 1991 Feb 29; 4(1):38-40. PubMed ID: 1903044
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 3-FG as substrate for investigating flux through the polyol pathway in dog lens by 19F-NMR spectroscopy.
    Lizak MJ, Secchi EF, Lee JW, Sato S, Kubo E, Akagi Y, Kador PF.
    Invest Ophthalmol Vis Sci; 1998 Dec 29; 39(13):2688-95. PubMed ID: 9856779
    [Abstract] [Full Text] [Related]

  • 17. Tissue-specific differences in 2-fluoro-2-deoxyglucose metabolism beyond FDG-6-P: a 19F NMR spectroscopy study in the rat.
    Southworth R, Parry CR, Parkes HG, Medina RA, Garlick PB.
    NMR Biomed; 2003 Dec 29; 16(8):494-502. PubMed ID: 14696007
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of 2-fluoro-2-deoxy-D-glucose metabolites by 19F(1H) hetero-RELAY.
    O'Connell TM, London RE.
    J Magn Reson B; 1995 Dec 29; 109(3):264-9. PubMed ID: 8542195
    [Abstract] [Full Text] [Related]

  • 20. In vivo metabolism of 3-deoxy-3-fluoro-D-glucose.
    Berkowitz BA, Moriyama T, Fales HM, Byrd RA, Balaban RS.
    J Biol Chem; 1990 Jul 25; 265(21):12417-23. PubMed ID: 2115519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.